Enovis (NYSE: ENOV) revenue
Enovis reported revenue of $2,248m for fiscal 2025, 6.7% more than in fiscal 2024 ($2,108m). Since fiscal 2016 its revenue has fallen by 29.4%, an average decline of 3.8% a year.
Enovis has grown its revenue for 5 years in a row, and its best year of the last 10 was fiscal 2019. The biggest drop was in fiscal 2020, −66.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $2,248m | +6.7% | −$1,124m | −50.0% |
| 2024 | $2,108m | +23.5% | −$775.7m | −36.8% |
| 2023 | $1,707m | +9.2% | −$65.7m | −3.8% |
| 2022 | $1,563m | +9.6% | −$71.2m | −4.6% |
| 2021 | $1,426m | +27.3% | −$62.8m | −4.4% |
| 2020 | $1,121m | −66.3% | −$66.2m | −5.9% |
| 2019 | $3,327m | +51.7% | $203.6m | 6.1% |
| 2018 | $2,193m | +13.2% | $151.5m | 6.9% |
| 2017 | $1,937m | −39.2% | $135.6m | 7.0% |
| 2016 | $3,186m | — | $236.8m | 7.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Enovis revenue compared with its sector
By revenue for its latest fiscal year, Enovis ranks 108th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Enovis, 6.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 106th | Exelixis | $2,320m | 7.0% |
| 107th | Natera | $2,306m | 35.9% |
| 108th | Enovis | $2,248m | 6.7% |
| 109th | ICU Medical | $2,231m | −6.3% |
| 110th | Sarepta Therapeutics | $2,198m | 15.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Enovis
- How much revenue did Enovis make in fiscal 2025?
- Enovis reported revenue of $2,248m for fiscal 2025, compared with $2,108m in fiscal 2024.
- How much has the revenue of Enovis fallen?
- Between fiscal 2016 and fiscal 2025 it went from $3,186m to $2,248m: 29.4% less, an average decline of 3.8% a year.
- What was the best year for revenue at Enovis?
- Of its last 10 fiscal years, fiscal 2019, with $3,327m.
- Where does Enovis rank in its sector by revenue?
- It ranks 108th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Enovis come from?
- From the annual report (Form 10-K) that Enovis files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Enovis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Enovis: the Enovis page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.